TY  - CONF

T1  - Effects of the VEGFR-2 tyrosine kinase inhibitor ZD6474 and docetaxel on circulating endothetial cells (CEC): Implications for use as a surrogate marker.

JO  - CLINICAL CANCER RESEARCH

PY  - 2003/01/01

AU  - Heymach MJ

AU  - Force JM

AU  - Beaudry P

AU  - Wang AC

AU  - Baker C

AU  - Ryan A

AU  - Folkman J

AU  - Soker S

ED  - 

VL  - 9

IS  - 16

SP  - 6141S

EP  - 6141S

Y2  - 2024/10/23

ER  -